Taiyen Biotech Co Ltd
TWSE:1737
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/OCF
Price to Operating Cash Flow (P/OCF) ratio compares a company`s market value to the cash it generates from its core operations.
Price to Operating Cash Flow (P/OCF) ratio compares a company`s market value to the cash it generates from its core operations.
Valuation Scenarios
If P/OCF returns to its 3-Year Average (11.8), the stock would be worth NT$25.54 (19% downside from current price).
| Scenario | P/OCF Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 14.7 | NT$31.7 |
0%
|
| 3-Year Average | 11.8 | NT$25.54 |
-19%
|
| 5-Year Average | 14.1 | NT$30.45 |
-4%
|
| Industry Average | 10.2 | NT$22.11 |
-30%
|
| Country Average | 13.2 | NT$28.43 |
-10%
|
Forward P/OCF
Today’s price vs future operating cash flow
Peer Comparison
| Market Cap | P/OCF | P/E | ||||
|---|---|---|---|---|---|---|
| TW |
|
Taiyen Biotech Co Ltd
TWSE:1737
|
6.3B TWD | 14.7 | 15.9 | |
| JP |
G
|
Goyo Foods Industry Co Ltd
TSE:2230
|
53.2T JPY | 324 863.9 | 540 752.8 | |
| CH |
|
Nestle SA
SIX:NESN
|
206.9B CHF | 12.9 | 22.7 | |
| US |
|
Mondelez International Inc
NASDAQ:MDLZ
|
75B USD | 16.6 | 30.6 | |
| FR |
|
Danone SA
PAR:BN
|
43.1B EUR | 11.3 | 23.5 | |
| ZA |
T
|
Tiger Brands Ltd
JSE:TBS
|
48.7B ZAR | 21.4 | 12.8 | |
| US |
|
Hershey Co
NYSE:HSY
|
38.1B USD | 16.7 | 43.2 | |
| CN |
|
Foshan Haitian Flavouring and Food Co Ltd
SSE:603288
|
229.3B CNY | 29.6 | 32.6 | |
| CN |
|
Muyuan Foods Co Ltd
SZSE:002714
|
236.5B CNY | 11.4 | 25.2 | |
| ZA |
A
|
Avi Ltd
JSE:AVI
|
33B ZAR | 10.8 | 12.8 | |
| CH |
|
Chocoladefabriken Lindt & Spruengli AG
SIX:LISN
|
23B CHF | 44.1 | 31.6 |
Market Distribution
| Min | 0.5 |
| 30th Percentile | 8.9 |
| Median | 13.2 |
| 70th Percentile | 20.4 |
| Max | 5 587.5 |
Other Multiples
Taiyen Biotech Co Ltd
Glance View
Taiyen Biotech Co., Ltd. is engaged in the manufacture, research and development of salt, beauty care, bottled water, cleaning and health food products. The company is headquartered in Tainan, Tainan. The company went IPO on 2003-11-18. The firm offers salt products, skin care and cosmetics, bottled water products, facial and body cleansers, health and dietary supplements, as well as other products, such as collagen raw materials, biomedical materials, microbial agents and others. The Company’s salt products include fine salts, dried salts, low sodium salts, bay salts and other salts, which are applied in industry, agriculture, food processing, cooking and others. The firm distributes its products in Taiwan market and to overseas markets.
